Fleming W H, Sarafian L B, Kugler J D, Hofschire P J, Clark E B
Ann Thorac Surg. 1981 Apr;31(4):329-33. doi: 10.1016/s0003-4975(10)60960-5.
Permanent pacemakers were implanted in 50 children. Indications were symptomatic sinus node dysfunction in 34 (68%), surgical block in 9 (18%), and congenital block in 7 (14%). Twenty-three (68%) of the 34 children with sinus node dysfunction had undergone prior cardiac operations. Only 4 of the 50 patients (8%) had electrode problems after a mean pacing time of 29.5 months (range, 1 to 96 months). All 35 of the mercury-cell pulse generators used in 28 patients ceased to function after an average useful life of 20.8 months (range, 1 to 51 months). The lithium-powered units in the 45 survivors all show satisfactory pacing after 5 to 44 months (mean, 28.1 months). With improved pacemaker technology, longer survival after complex repairs, and better monitoring techniques, the indications for cardiac pacing in children have broadened. Surgical block now is an indication in only a small fraction of the pediatric pacemaker population. Sinus node dysfunction accounts for an ever-increasing majority of the pacemakers we currently implant in children.
50名儿童植入了永久性起搏器。植入指征为:34例(68%)有症状性窦房结功能障碍,9例(18%)为外科手术导致的传导阻滞,7例(14%)为先天性传导阻滞。34例窦房结功能障碍患儿中,23例(68%)曾接受过心脏手术。50例患者中只有4例(8%)在平均起搏时间29.5个月(范围1至96个月)后出现电极问题。28例患者使用的35个汞电池脉冲发生器在平均使用寿命20.8个月(范围1至51个月)后均停止工作。45名存活患者使用的锂供电装置在5至44个月(平均28.1个月)后起搏情况均令人满意。随着起搏器技术的改进、复杂修复术后生存期的延长以及监测技术的提高,儿童心脏起搏的指征有所拓宽。目前,外科手术导致的传导阻滞仅占小儿起搏器植入人群的一小部分。窦房结功能障碍在我们目前为儿童植入的起搏器中所占比例越来越大。